RL
PFE icon

Ruffer LLP’s Pfizer PFE Stock Holding History

Ruffer LLP’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1M Sell
1,126,006
-23,747
-2% -$621K 0.96% 32
2026
Q1 		$32.4M Sell
1,149,753
-174,343
-13% -$4.64M 1.32% 21
2025
Q4 		$33M Sell
1,324,096
-698,969
-35% -$17.6M 1.5% 20
2025
Q3 		$51.5M Buy
2,023,065
+623,552
+45% +$15.4M 2.87% 11
2025
Q2 		$33.9M Sell
1,399,513
-792,785
-36% -$18.5M 1.5% 16
2025
Q1 		$55.6M Sell
2,192,298
-2,014,089
-48% -$52.7M 2.14% 10
2024
Q4 		$112M Sell
4,206,387
-2,319,901
-36% -$62.9M 4.03% 8
2024
Q3 		$189M Buy
6,526,288
+797,593
+14% +$23.3M 5.95% 6
2024
Q2 		$160M Sell
5,728,695
-178,963
-3% -$4.93M 6.88% 5
2024
Q1 		$164M Buy
5,907,658
+111,646
+2% +$3.1M 6.31% 4
2023
Q4 		$167M Buy
5,796,012
+4,133,786
+249% +$125M 6.2% 5
2023
Q3 		$53.3M Buy
1,662,226
+489,177
+42% +$17.3M 2.95% 12
2023
Q2 		$43M Buy
1,173,049
+101,370
+9% +$3.95M 2.52% 14
2023
Q1 		$43.7M Buy
1,071,679
+508,764
+90% +$22M 1.51% 24
2022
Q4 		$28.9M Buy
562,915
+8,140
+1% +$390K 1.94% 19
2022
Q3 		$23.9M Buy
554,775
+10,090
+2% +$490K 1.5% 22
2022
Q2 		$28.6M Sell
544,685
-33,949
-6% -$1.73M 1.13% 26
2022
Q1 		$30M Buy
578,634
+19,280
+3% +$1M 0.7% 33
2021
Q4 		$31.8M Buy
559,354
+124,464
+29% +$6.17M 0.77% 35
2021
Q3 		$18.6M Buy
434,890
+227,047
+109% +$10.1M 0.59% 30
2021
Q2 		$8.14M Buy
+207,843
New +$8.08M 0.23% 36
2015
Q2 		– Sell
-6,318
Closed -$209K – 101
2015
Q1 		$209K Buy
+6,318
New +$201K 0.01% 89
2014
Q3 		– Sell
-7,483
Closed -$213K – 89
2014
Q2 		$213K Hold
7,483
– – 0.01% 85
2014
Q1 		$228K Hold
7,483
– – 0.01% 89
2013
Q4 		$217K Hold
7,483
– – 0.01% 85
2013
Q3 		$206K Buy
+7,483
New +$204K 0.01% 84

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Ruffer LLP's PFE Position: Q2 2026 in Review

Ruffer LLP reduced its Pfizer (PFE) stake by 2.1% in Q2 2026, selling an estimated $621K and leaving 1,126,006 shares worth $27.1M. The position accounts for 0.96% of the portfolio, ranked #32.

Ruffer LLP first reported a position in PFE in Q3 2013 and has held it in 26 quarters since. The position peaked at $189M in Q3 2024. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ruffer LLP held 1,126,006 shares of Pfizer worth $27.1M as of Q2 2026.
  • Ruffer LLP sold 23,747 Pfizer shares in Q2 2026, an estimated $621K.
  • Pfizer made up 0.96% of Ruffer LLP's portfolio in Q2 2026, its #32 holding.
  • Ruffer LLP first reported a position in Pfizer in Q3 2013 and has held it in 26 quarters since.
  • Ruffer LLP's Pfizer position peaked at $189M in Q3 2024.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ruffer LLP's 13F filing for Q2 2026, filed 30 Jul 2026.